TREAT CTC (BIG 1-12)
Intro text:
Page under construction!
TRastuzumab treatment for HER2-negative early breast cancer in the presence of circulating tumor cells
- ClinicalTrials.gov Identifier: NCT01548677
TRastuzumab treatment for HER2-negative early breast cancer in the presence of circulating tumor cells